Literature DB >> 17610601

Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications.

M E Falagas1, E G Mourtzoukou, M Polemis, A C Vatopoulos.   

Abstract

This study analysed the proportions of Acinetobacter baumannii isolates resistant to various antibiotics that were recovered from patients hospitalised in Greek hospitals between 1996 and 2006. The microbiological data were derived from the ongoing WHONET Greek System for the Surveillance of Antibiotic Resistance. There were increases in the proportions of A. baumannii isolates resistant to imipenem from patients hospitalised in intensive care units, medical wards and surgical wards during the study period from 0% to 91%, 8% to 71%, and 5% to 71%, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610601     DOI: 10.1111/j.1469-0691.2007.01761.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

Review 1.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

2.  Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system.

Authors:  Ting L Luo; Alexander H Rickard; Usha Srinivasan; Keith S Kaye; Betsy Foxman
Journal:  Front Microbiol       Date:  2015-03-12       Impact factor: 5.640

3.  Clinico-epidemiological nature and antibiotic susceptibility profile of Acinetobacter species.

Authors:  Shirin Biglari; Alfizah Hanafiah; Ramliza Ramli; Md Mostafizur Rahman; Tzar Mohd Nizam Khaithir
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

4.  Use of WHONET-SaTScan system for simulated real-time detection of antimicrobial resistance clusters in a hospital in Italy, 2012 to 2014.

Authors:  Alessandra Natale; John Stelling; Marcello Meledandri; Louisa A Messenger; Fortunato D'Ancona
Journal:  Euro Surveill       Date:  2017-03-16

5.  Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models.

Authors:  Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; George Ismailos; Vangelis Karalis
Journal:  Pathogens       Date:  2021-04-15

6.  A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.

Authors:  Sofia Maraki; Elpis Mantadakis; Viktoria Eirini Mavromanolaki; Diamantis P Kofteridis; George Samonis
Journal:  Infect Chemother       Date:  2016-09-09

7.  Determination of imipenem efflux-mediated resistance in Acinetobacter spp., using an efflux pump inhibitor.

Authors:  Ghazale Amiri; Maryam Abbasi Shaye; Masoumeh Bahreini; Asghar Mafinezhad; Kiarash Ghazvini; Mohammad Reza Sharifmoghadam
Journal:  Iran J Microbiol       Date:  2019-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.